Scala Biodesign makes it easy to re-engineer proteins one molecule at a time – or 50

There’s a gold rush on in biotech as AI and other tools are used to find new drugs and treatments. With $5.5 million in new funding, Scala Biodesign is focusing these methods on a related problem: making existing or promising drugs more practical by tweaking them one (or more) molecule at at time. The founders […]
Source: TECCRUCH

リンク元